Literature DB >> 10377434

Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes.

O Rötzschke1, K Falk, J Mack, J M Lau, G Jung, J L Strominger.   

Abstract

Class II MHC molecules are known to exist in conformational variants. "Floppy" and "compact" forms of murine MHC molecules, for example, are discriminated by their migration behavior on SDS/PAGE and represent empty and ligand-loaded forms. Here we show that formation of distinctly faster-migrating ligand complexes (F-forms) rather than the normal compact (C-) forms of HLA-DR1 or -DR4 results from extensions of minimal peptide epitopes (such as HA306-318 or IC106-120) by approximately 10 amino acids at either the N or the C terminus. Two similar but distinct F-forms (FI and FII) were detected, depending on the site of the extension. Both F-forms were characterized by increased surface hydrophobicity and reduced SDS-stability. Native gel separations and size exclusion chromatography indicated that the F-forms had increased hydrodynamic radii compared with the C-form and an apparent size similar to that of empty MHC molecules. The regions on the ligand overhangs responsible for the effect began at a distance of approximately 5 amino acids on either side of the epitopes, comprised 4-8 amino acids (i.e., a total overhang of 9-14), and did not have a particular sequence preference. The possible functional significance of these forms is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377434      PMCID: PMC22105          DOI: 10.1073/pnas.96.13.7445

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides.

Authors:  S K Natarajan; M Assadi; S Sadegh-Nasseri
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

2.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.

Authors:  R M Chicz; R G Urban; W S Lane; J C Gorga; L J Stern; D A Vignali; J L Strominger
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

Review 3.  Endocytosis and signals for internalization.

Authors:  I S Trowbridge
Journal:  Curr Opin Cell Biol       Date:  1991-08       Impact factor: 8.382

4.  Conformational isomers of a class II MHC-peptide complex in solution.

Authors:  L Schmitt; J J Boniface; M M Davis; H M McConnell
Journal:  J Mol Biol       Date:  1999-02-12       Impact factor: 5.469

5.  Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1.

Authors:  D Teitelbaum; R Aharoni; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.

Authors:  S K Natarajan; L J Stern; S Sadegh-Nasseri
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

7.  Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin.

Authors:  J R Lamb; D D Eckels; P Lake; J N Woody; N Green
Journal:  Nature       Date:  1982-11-04       Impact factor: 49.962

8.  Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.

Authors:  T S Jardetzky; J C Gorga; R Busch; J Rothbard; J L Strominger; D C Wiley
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

9.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease.

Authors:  G P Shi; J S Munger; J P Meara; D H Rich; H A Chapman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

10.  Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.

Authors:  G Malcherek; V Gnau; G Jung; H G Rammensee; A Melms
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  7 in total

1.  Amino acid polymorphisms in the fibronectin-binding repeats of fibronectin-binding protein A affect bond strength and fibronectin conformation.

Authors:  Nadia N Casillas-Ituarte; Carlos H B Cruz; Roberto D Lins; Alex C DiBartola; Jessica Howard; Xiaowen Liang; Magnus Höök; Isabelle F T Viana; M Roxana Sierra-Hernández; Steven K Lower
Journal:  J Biol Chem       Date:  2017-04-11       Impact factor: 5.157

2.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

3.  A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules.

Authors:  Olaf Rötzschke; Julie M Lau; Maria Hofstätter; Kirsten Falk; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

4.  Paradoxical intrathymic positive selection in mice with only a covalently presented agonist peptide.

Authors:  C Viret; X He; C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Synthetic High-density Lipoprotein Nanodiscs for Personalized Immunotherapy Against Gliomas.

Authors:  Lindsay Scheetz; Padma Kadiyala; Xiaoqi Sun; Sejin Son; Alireza Hassani Najafabadi; Marisa Aikins; Pedro R Lowenstein; Anna Schwendeman; Maria G Castro; James J Moon
Journal:  Clin Cancer Res       Date:  2020-05-21       Impact factor: 12.531

Review 6.  Development of designed site-directed pseudopeptide-peptido-mimetic immunogens as novel minimal subunit-vaccine candidates for malaria.

Authors:  José Manuel Lozano; Liliana P Lesmes; Luisa F Carreño; Gina M Gallego; Manuel Elkin Patarroyo
Journal:  Molecules       Date:  2010-12-06       Impact factor: 4.411

7.  Prediction of peptides binding to MHC class I and II alleles by temporal motif mining.

Authors:  Cem Meydan; Hasan H Otu; Osman Uğur Sezerman
Journal:  BMC Bioinformatics       Date:  2013-01-21       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.